We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$52.5B
AUM Growth
-$1.16B
(-2.2%)
Cap. Flow
-$399M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
2,386
New
193
Increased
800
Reduced
1,005
Closed
184
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXO Logistics
GXO
|
+$161M |
| 2 |
Invivyd
IVVD
|
+$94.7M |
| 3 |
Freeport-McMoran
FCX
|
+$88.6M |
| 4 |
Amgen
AMGN
|
+$87.7M |
| 5 |
Truist Financial
TFC
|
+$83.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$296M |
| 2 |
Pfizer
PFE
|
+$276M |
| 3 |
Cisco
CSCO
|
+$151M |
| 4 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
+$103M |
| 5 |
Evergy
EVRG
|
+$99.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.48% |
| 2 | Technology | 20.59% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HI
501
DELISTED
Hillenbrand
HI
| $17.7M | 0.03% |
415,285
-2,704
| -0.6% | -$119K |
|
|
RUBY
502
DELISTED
Rubius Therapeutics, Inc
RUBY
| $17.7M | 0.03% |
989,100
-159,155
| -14% | -$3.46M |
|
503
Teladoc Health
TDOC
$1.2B
| $17.6M | 0.03% |
139,000
+26,457
| +24% | +$3.85M |
|
504
Starbucks
SBUX
$110B
| $17.6M | 0.03% |
159,198
+77,035
| +94% | +$9.02M |
|
505
Ambarella
AMBA
$2.84B
| $17.6M | 0.03% |
112,725
-34,822
| -24% | -$4M |
|
506
OptimizeRx
OPRX
$142M
| $17.5M | 0.03% |
204,970
+40,291
| +24% | +$2.53M |
|
507
ICICI Bank
IBN
$102B
| $17.4M | 0.03% |
922,601
+47,232
| +5% | +$885K |
|
508
Macy's
M
$5.77B
| $17.4M | 0.03% |
770,109
+382,598
| +99% | +$7.65M |
|
|
VERV
509
DELISTED
Verve Therapeutics
VERV
| $17.4M | 0.03% |
370,000
| – | – |
|
510
Twist Bioscience
TWST
$9.16B
| $17.4M | 0.03% |
162,300
| – | – |
|
|
LENZ
511
LENZ Therapeutics
LENZ
$133M
| $17.3M | 0.03% |
150,901
+58,044
| +63% | +$8.6M |
|
512
Bristol-Myers Squibb
BMY
$130B
| $17.3M | 0.03% |
291,981
+70,793
| +32% | +$4.66M |
|
513
Constellation Brands
STZ
$21.1B
| $17.2M | 0.03% |
81,805
-49
| -0.1% | -$10.7K |
|
514
Levi Strauss
LEVI
$7.63B
| $17.2M | 0.03% |
702,891
-64,075
| -8% | -$1.73M |
|
515
Clarivate
CLVT
$1.22B
| $17.2M | 0.03% |
785,500
| – | – |
|
516
Denali Therapeutics
DNLI
$3.26B
| $17.1M | 0.03% |
339,160
+200,528
| +145% | +$11.3M |
|
517
Cheniere Energy
LNG
$56B
| $17.1M | 0.03% |
174,682
+170,296
| +3,883% | +$14.9M |
|
518
Coca-Cola Consolidated
COKE
$13.2B
| $17M | 0.03% |
432,400
+23,970
| +6% | +$954K |
|
519
Shutterstock
SSTK
$180M
| $17M | 0.03% |
150,296
+18,962
| +14% | +$2.05M |
|
|
RADA
520
DELISTED
Rada Electronic Industries Ltd
RADA
| $17M | 0.03% |
1,600,000
| – | – |
|
|
ZUO
521
DELISTED
Zuora, Inc.
ZUO
| $16.9M | 0.03% |
1,016,573
+371,549
| +58% | +$6.26M |
|
522
Minerva Neurosciences
NERV
$183M
| $16.7M | 0.03% |
1,201,275
| – | – |
|
523
Huntington Ingalls Industries
HII
$11B
| $16.6M | 0.03% |
86,047
-337
| -0.4% | -$68.2K |
|
524
United Rentals
URI
$61.6B
| $16.3M | 0.03% |
46,580
-5,387
| -10% | -$1.81M |
|
525
Grocery Outlet
GO
$1.14B
| $16.3M | 0.03% |
754,847
-571,468
| -43% | -$16.4M |
|
Similar funds
Federated Hermes's Q3 2021 Portfolio in Review
As of Q3 2021, Federated Hermes held 2,386 positions worth $52.5B, down 2.2% from $53.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Federated Hermes's Q3 2021 filing shows 193 new, 800 increased, 1,005 reduced and 184 closed positions. Its largest new stake was GXO Logistics: 2,051,695 shares worth $161M. The largest sale was Moderna, an estimated $296M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2021 buy was GXO Logistics: 2,051,695 shares worth $161M.
- Federated Hermes added most to Freeport-McMoran in Q3 2021, an estimated $88.6M increase.
- Federated Hermes's biggest Q3 2021 reduction was Moderna, cutting an estimated $296M.
- Federated Hermes fully exited Translate Bio, Inc. Common Stock in Q3 2021, selling an estimated $103M.
- Federated Hermes's ten largest holdings make up 12% of its $52.5B portfolio in Q3 2021.
- Federated Hermes opened 193 new positions and closed 184 in Q3 2021.
- Federated Hermes's portfolio value fell 2.2% quarter-over-quarter to $52.5B.
Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.